Neuro-oncology

Keyphrases

Publications

volume 26, number 8, 2024

Ying Zhang, Kadie Hudson, Roger Abounader
Unraveling the hypoxic puzzle: LncRNA LUCAT1 drives glioblastoma in cooperation with HIF1α. Neuro-oncology 26 (8) (2024)
Josephine D Hendriksen, Alessio Locallo, Simone Maarup, Olivia Debnath, Naveed Ishaque, Benedikte Hasselbalch, Jane Skjøth-Rasmussen, Christina Westmose Yde, Hans Skovgaard Poulsen, Ulrik N Lassen, Joachim Weischenfeldt
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients. Neuro-oncology 26 (8) (2024)
Rifaquat Rahman, Diana D Shi, Zachary J Reitman, Petra Hamerlik, John F de Groot, Daphne A Haas-Kogan, Alan D D'Andrea, Erik P Sulman, Kirk Tanner, Nathalie Y R Agar, Jann N Sarkaria, Christopher L Tinkle, Ranjit S Bindra, Minesh P Mehta, Patrick Yung Wen
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology. Neuro-oncology 26 (8) (2024)
Patricia O'Hare, Tabitha Cooney, Peter de Blank, David H Gutmann, Mark Kieran, Till Milde, Jason Fangusaro, Michael Fisher, Shivaram Avula, Roger Packer, Kohei Fukuoka, Kshitij Mankad, Sabine Mueller, Angela J Waanders, Enrico Opocher, Eric Bouffet, Eric Raabe, Natacha Entz Werle, Amedeo A Azizi, Nathan J Robison, Pablo Hernáiz Driever, Mark Russo, Netteke Schouten, Cornelis M van Tilburg, Astrid Sehested, Jacques Grill, Pratiti Bandopadhayay, John-Paul Kilday, Olaf Witt, David M Ashley, Birgit Betina Ertl-Wagner, Uri Tabori, Darren R Hargrave
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. Neuro-oncology 26 (8) (2024)
Corina Anastasaki, Jit Chatterjee, Joshua P Koleske, Yunqing Gao, Stephanie L Bozeman, Chloe M Kernan, Lara I Marco Y Marquez, Ji-Kang Chen, Caitlin E Kelly, Connor J Blair, Dennis J Dietzen, Robert A Kesterson, David H Gutmann
NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma. Neuro-oncology 26 (8) (2024)
Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, Marisol Gonzalez-Huarriz, Andrea Lacalle, Noelia Casares, Marta Zalacain, Lucía Marrodan, Marc García-Moure, Maria C Ochoa, Antonio Carlos Tallon-Cobos, Reyes Hernandez-Osuna, Javier Marco-Sanz, Laasya Dhandapani, Irati Hervás-Corpión, Oren J Becher, Javad Nazarian, Sabine Mueller, Timothy N Phoenix, Jasper van der Lugt, Mikel Hernaez, Elizabeth Guruceaga, Carl J Koschmann, Sriram Venneti, Joshua E Allen, Matthew D Dun, Juan Fueyo, Candelaria Gomez-Manzano, Jaime Gallego Perez-Larraya, Ana Patiño-García, Sara Labiano, Marta Marija Alonso
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro-oncology 26 (8) (2024)
Ying Zhang, Kadie Hudson, Roger Abounader
Diffuse midline (H3 K27M-mutant) glioma in adults-When resection fails to matter. Neuro-oncology 26 (8) (2024)
Fariba Tohidinezhad, Catharina M L Zegers, Femke Vaassen, Jeanette Dijkstra, Monique Anten, Wouter Van Elmpt, Dirk De Ruysscher, Andre Dekker, Daniëlle B P Eekers, Alberto Traverso
Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor. Neuro-oncology 26 (8) (2024)
Han Xie, Yanyi Jiang, Yufei Xiang, Baoming Wu, Jiajia Zhao, Ruixiang Huang, Mengting Wang, Yunlong Wang, Jun Liu, Dejun Wu, Dasheng Tian, Erbao Bian
Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia. Neuro-oncology 26 (8) (2024)
Philipp Karschnia, Joerg-Christian Tonn
Shaping the future of molecular neurosurgery: Toward epigenetic precision in surgical neuro-oncology? Neuro-oncology 26 (8) (2024)
Jana Ivanidze, Se Jung Chang, Arsalan Haghdel, Joon Tae Kim, Arindam Roy Choudhury, Alan Wu, Rohan R Ramakrishna, Theodore H Schwartz, Babacar Cisse, Philip Stieg, Leland Muller, Joseph R Osborne, Rajiv S Magge, Nicolas A Karakatsanis, Michelle Roytman, Eaton Lin, Susan C Pannullo, Joshua David Palmer, Jonathan P S Knisely
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas. Neuro-oncology 26 (8) (2024)
Martina Offi, Lucia Gabriele, Giulia Romagnoli, Liverana Lauretti, Roberto Pallini, Quintino Giorgio D'Alessandris
The Sybil prophecy: Searching for predictors of response to bevacizumab in glioblastoma. Neuro-oncology 26 (8) (2024)
Lisa Dobber, Marjolein Geurts, Martin J Van Den Bent
Tumor growth in recurrent glioblastoma-RANO: when to plan the baseline scan? Neuro-oncology 26 (8) (2024)
Alice Ryba, Zeynep Özdemir, Nitzan Nissimov, Lisa Hönikl, Nicolas Neidert, Martin Jakobs, Darius Kalasauskas, Aleksandrs Krigers, Claudius Thomé, Christian F Freyschlag, Florian Ringel, Andreas Unterberg, Philip Dao Trong, Jürgen Beck, Dieter Henrik Heiland, Bernhard Meyer, Peter Vajkoczy, Julia Onken, Walter Stummer, Eric Suero Molina, Jens Gempt, Manfred Westphal, Ulrich Schüller, Malte Mohme
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticator. Neuro-oncology 26 (8) (2024)
Shreya Budhiraja, Graysen McManus, Shivani Baisiwala, Ella N Perrault, Sia Cho, Miranda Saathoff, Li Chen, Cheol H Park, Hasaan A Kazi, Crismita Dmello, Peiyu Lin, C David James, Adam M Sonabend, Dieter H Heiland, Atique U Ahmed
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma. Neuro-oncology 26 (8) (2024)
Haidong Huang, Hariti Shah, Jing Hao, Jianhong Lin, Richard A Prayson, Liangqi Xie, Shideng Bao, Abhishek A Chakraborty, Eckhard Jankowsky, Jianjun Zhao, Jennifer S Yu
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity. Neuro-oncology 26 (8) (2024)
Shixue Yang, Qi Zhan, Dongyuan Su, Xiaoteng Cui, Jixing Zhao, Qixue Wang, Biao Hong, Jiasheng Ju, Chunchao Cheng, Eryan Yang, Chun-Sheng Kang
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma. Neuro-oncology 26 (8) (2024)

volume 26, number Supplement_1, 2024

Matthew Gallitto, Peter C Pan, Michael D Chan, Michael T Milano, Tony J C Wang
The role of radiotherapy in immunotherapy strategies in the central nervous system. Neuro-oncology 26 (Supplement_1) (2024)
William G Breen, Madhava P Aryal, Yue Cao, Michelle M Kim
Integrating multi-modal imaging in radiation treatments for glioblastoma. Neuro-oncology 26 (Supplement_1) (2024)
Joshua David Palmer, Haley K Perlow, Eric J Lehrer, Zabi Wardak, Hany Soliman
Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma. Neuro-oncology 26 (Supplement_1) (2024)
Amanda N Sacino, Hanbo Chen, Arjun Sahgal, Chetan Bettegowda, Laurence D Rhines, Pejman Maralani, Kristin J Redmond
Stereotactic body radiation therapy for spinal metastases: A new standard of care. Neuro-oncology 26 (Supplement_1) (2024)
Zachary S Mayo, Cole Billena, John H Suh, Simon S Lo, Samuel T Chao
The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases. Neuro-oncology 26 (Supplement_1) (2024)
Rupesh R Kotecha, Alonso La Rosa, Minesh P Mehta
How proton therapy fits into the management of adult intracranial tumors. Neuro-oncology 26 (Supplement_1) (2024)
Chia-Lin Tseng, K Liang Zeng, Eric A Mellon, Scott G Soltys, Mark Ruschin, Angus Z Lau, Natalia S Lutsik, Rachel W Chan, Jay S Detsky, James Stewart, Pejman J Maralani, Arjun Sahgal
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon. Neuro-oncology 26 (Supplement_1) (2024)
Arjun Sahgal, Susan Chang
Pushing the boundaries of radiation technology for the management of central nervous system tumors. Neuro-oncology 26 (Supplement_1) (2024)

volume 26, number Supplement_2, 2024

Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel C Arrillaga-Romany, Doured Daghistani, Minesh P Mehta, Rohinton S Tarapore, Samuel C Ramage, Joshua E Allen
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel C Arrillaga-Romany, Doured Daghistani, Minesh P Mehta, Rohinton S Tarapore, Samuel C Ramage, Joshua E Allen
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Neuro-oncology 26 (Supplement_2) (2024)
Matthew D Dun, Yazmin Odia, Isabel C Arrillaga-Romany
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors, Martin van den Bent, Michael A Vogelbaum, Joshua E Allen, Allen S Melemed, Rohinton S Tarapore, Patrick Y Wen, Timothy Cloughesy
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel C Arrillaga-Romany, Doured Daghistani, Minesh P Mehta, Rohinton S Tarapore, Samuel C Ramage, Joshua E Allen
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Neuro-oncology 26 (Supplement_2) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors, Martin van den Bent, Michael A Vogelbaum, Joshua E Allen, Allen S Melemed, Rohinton S Tarapore, Patrick Y Wen, Timothy Cloughesy
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Matthew D Dun, Yazmin Odia, Isabel C Arrillaga-Romany
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon. Neuro-oncology 26 (Supplement_2) (2024)
Romain Mueller, Cassie Kline, Andrea Franson, Jasper van der Lugt, Michael Prados, Sebastian M Waszak, Sabine L A Plasschaert, Annette M Molinaro, Carl Koschmann, Javad Nazarian
Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC. Neuro-oncology 26 (Supplement_2) (2024)
Matthew D Dun, Yazmin Odia, Isabel C Arrillaga-Romany
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors, Martin van den Bent, Michael A Vogelbaum, Joshua E Allen, Allen S Melemed, Rohinton S Tarapore, Patrick Y Wen, Timothy Cloughesy
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Romain Mueller, Cassie Kline, Andrea Franson, Jasper van der Lugt, Michael Prados, Sebastian M Waszak, Sabine L A Plasschaert, Annette M Molinaro, Carl Koschmann, Javad Nazarian
Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC. Neuro-oncology 26 (Supplement_2) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors, Martin van den Bent, Michael A Vogelbaum, Joshua E Allen, Allen S Melemed, Rohinton S Tarapore, Patrick Y Wen, Timothy Cloughesy
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel C Arrillaga-Romany, Doured Daghistani, Minesh P Mehta, Rohinton S Tarapore, Samuel C Ramage, Joshua E Allen
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Neuro-oncology 26 (Supplement_2) (2024)
Romain Mueller, Cassie Kline, Andrea Franson, Jasper van der Lugt, Michael Prados, Sebastian M Waszak, Sabine L A Plasschaert, Annette M Molinaro, Carl Koschmann, Javad Nazarian
Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC. Neuro-oncology 26 (Supplement_2) (2024)

volume 26, number Supplement_3, 2024

Mackenzie Price, Corey Neff, Nitin Nagarajan, Carol Kruchko, Kristin A Waite, Gino Cioffi, Brittany B Cordeiro, Nicole Willmarth, Marta Penas-Prado, Mark R Gilbert, Terri S Armstrong, Jill S Barnholtz-Sloan, Quinn T Ostrom
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Neuro-oncology 26 (Supplement_3) (2024)
Mackenzie Price, Corey Neff, Nitin Nagarajan, Carol Kruchko, Kristin A Waite, Gino Cioffi, Brittany B Cordeiro, Nicole Willmarth, Marta Penas-Prado, Mark R Gilbert, Terri S Armstrong, Jill S Barnholtz-Sloan, Quinn T Ostrom
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Neuro-oncology 26 (Supplement_3) (2024)